Status
Conditions
Treatments
About
The purpose of this study is to evaluate antibody levels against Group B streptococcus in mothers and the risk of developing invasive Group B streptococcus disease in newborns of less than 6 days age as well as infants of age less than 90 days age.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Subjects Refusing to consent to study participation.
Primary purpose
Allocation
Interventional model
Masking
3,033 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal